
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)
GlobeNewsWire
公開日時: Jul 13, 2026, 10:49 PM GMT+9
Sentiment Analysis
Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) against certain of its officers and directors for alleged breaches of fiduciary duty.
Shareholders who have held Treace shares continuously since prior to May 8, 2023, may have standing to seek corporate governance reforms, the return of funds back to the company, and a court-approved incentive award, all at no cost to them.
A previously filed securities class action complaint alleges that Treace and certain of its executives made materially false and misleading statements, and/or failed to disclose material adverse facts, concerning the Company's business, operations, and prospects.
The filed complaint alleges that defendants made false statements and/or concealed that: (1) competition impacted the demand for and utilization of its primary product, the 3D bunion correction system, the "Lapiplasty"; (2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realig...
Source: GlobeNewsWire
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。